Open Insider Trading Activity for Avalo Therapeutics, Inc. Chief Medical Officer Doyle Mittie
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-06-01 | 2026-05-28 | Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1 | 679 | $16.00 | $10,864.00 | 1.42% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-19 | 2026-05-15 | Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1 | 3,000 | $18.76 | $56,280.00 | 45.30% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-04-03 | 2026-04-01 | Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1 | 679 | $16.00 | $10,864.00 | 15.79% | View Filing |